Your shopping cart is currently empty

Saterinone is a potent and selective phosphodiesterase III inhibitor and a potent antagonist of the vascular α-1-adrenoceptor. Saterinone has vasodilatory properties and can be used in the acute treatment of chronic heart failure. Saterinone inhibited crude cAMP phosphodiesterase (PDE) activity in guinea pig right ventricular homogenates The ic50 value is 2.3 × 10(-5) mol/l.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $67 | In Stock | In Stock | |
| 5 mg | $163 | In Stock | In Stock | |
| 10 mg | $247 | In Stock | In Stock | |
| 25 mg | $396 | In Stock | In Stock | |
| 50 mg | $538 | In Stock | In Stock | |
| 100 mg | $721 | In Stock | In Stock | |
| 200 mg | $973 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $193 | In Stock | In Stock |
| Description | Saterinone is a potent and selective phosphodiesterase III inhibitor and a potent antagonist of the vascular α-1-adrenoceptor. Saterinone has vasodilatory properties and can be used in the acute treatment of chronic heart failure. Saterinone inhibited crude cAMP phosphodiesterase (PDE) activity in guinea pig right ventricular homogenates The ic50 value is 2.3 × 10(-5) mol/l. |
| Targets&IC50 | Pig papillary muscles:9.1 mumol/l(EC50), Isoenzyme III:0.06 mumol/l |
| In vitro | Saterinone selectively and potently inhibited the isoenzyme III of PDE (IC50 = 0.06 mumol/l). Thus, saterinone proved to be a selective inhibitor of 'low-Km, cAMP specific' PDE III.[1] |
| In vivo | Saterinone (1-30 mumol/l) exerted a concentration-dependent positive inotropic effect (EC50 = 9.1 mumol/l) in guinea pig papillary muscles.[1] |
| Molecular Weight | 474.55 |
| Formula | C27H30N4O4 |
| Cas No. | 102669-89-6 |
| Smiles | CC1=C(C=C(C#N)C(=O)N1)C2=CC=C(OCC(CN3CCN(CC3)C4=C(OC)C=CC=C4)O)C=C2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||
| Solubility Information | DMSO: 4.75 mg/mL (10.01 mM), Sonication is recommended. | ||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||
DMSO
| |||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.